Skip to main content

Conscious Sedation

5
Pipeline Programs
9
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
3
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
1
Nitrous OxidePhase 41 trial
OndansetronN/A1 trial
Active Trials
NCT00387556Completed268Est. Dec 2006
NCT03085563Completed63Est. Nov 2018
Maruishi Pharmaceutical
1 program
1
DexmedetomidinePhase 4
Pfizer
PfizerNEW YORK, NY
1 program
1
DexmedetomidinePhase 41 trial
Active Trials
NCT00318955Completed85Est. Aug 2006
Orion Pharma
Orion PharmaUK - Reading
1 program
1
DexmedetomidinePhase 31 trial
Active Trials
NCT00226785Terminated900Est. Jul 2006
Orion
OrionUK - Cambridge
1 program
1
DexmedetomidinePhase 3
GE HealthCare
1 program
DexmedetomidineN/A1 trial
Active Trials
NCT00641563Completed10Est. Jun 2004
Eisai
EisaiChina - Liaoning
1 program
AQUAVAN®PHASE_31 trial
Active Trials
NCT00261599Completed300Est. Oct 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado TherapeuticsNitrous Oxide
PfizerDexmedetomidine
EisaiAQUAVAN®
Orion PharmaDexmedetomidine
GE HealthCareDexmedetomidine
Colorado TherapeuticsOndansetron

Clinical Trials (6)

Total enrollment: 1,626 patients across 6 trials

A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department

Start: May 2017Est. completion: Nov 201863 patients
Phase 4Completed
NCT00318955PfizerDexmedetomidine

Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients

Start: Nov 2005Est. completion: Aug 200685 patients
Phase 4Completed

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy

Start: Mar 2006Est. completion: Oct 2006300 patients
Phase 3Completed

Dexmedetomidine for Continuous Sedation

Start: Oct 2005Est. completion: Jul 2006900 patients
Phase 3Terminated

Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG)

Start: Mar 2004Est. completion: Jun 200410 patients
N/ACompleted

Ondansetron Reduce Vomiting Associated With Ketamine PSA

Start: Dec 2002Est. completion: Dec 2006268 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.